(Q54798312)

3 June 2018

title

Expression of c-kit protein and mutational status of the c-kit gene in osteosarcoma and their clinicopathological significance. (English)

1 reference

3 June 2018

author name string

H Wei

1

1 reference

3 June 2018

M Q Zhao

2

1 reference

3 June 2018

W Dong

3

1 reference

3 June 2018

Y Yang

4

1 reference

3 June 2018

J S Li

5

1 reference

3 June 2018

publication date

1 September 2008

1 reference

3 June 2018

Journal of International Medical Research

published in

1 reference

3 June 2018

volume

36

1 reference

3 June 2018

issue

5

1 reference

3 June 2018

page(s)

1008-1014

1 reference

3 June 2018

Oncogenes and the strategy of growth factors

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

Class III receptor tyrosine kinases: role in leukaemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

Prognostic significance of allelic imbalance at the c-kit gene locus and c-kit overexpression by immunohistochemistry in pediatric osteosarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

Activating c-kit gene mutations in human germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

Expression of c-kit in human osteosarcoma and its relevance as a prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

The World Health Organization's histologic classification of bone tumors. A commentary on the second edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

C-kit expression in pediatric solid tumors: a comparative immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

Inhibition of spontaneous receptor phosphorylation by residues in a putative alpha-helix in the KIT intracellular juxtamembrane region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600518

10.1177/147323000803600518

21 January 2018

Identifiers

DOI

1 reference

3 June 2018

release_msudk4xrcbdjxfnzo63h53s2ky

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/msudk4xrcbdjxfnzo63h53s2ky

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

3 June 2018